82 phenotypes from 10 alleles in 10 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Tal1Hpt/Tal1+ (C57BL/6J x C3FeLe.B6-a/a)F1	abnormal coat appearance	J:13897
	abnormal hair follicle development	J:13897
	abnormal skin pigmentation	J:13897
	focal hair loss	J:13897
	sparse hair	J:13897
Tal1Hpt/Tal1+ HPT/Le	abnormal erythropoiesis	J:1780
	abnormal hair follicle development	J:1780
	abnormal hair growth	J:1780
	abnormal kidney morphology	J:1780
	abnormal podocyte foot process morphology	J:1780
	abnormal renal glomerulus morphology	J:1780
	abnormal skin pigmentation	J:1780
	alopecia	J:1780
	anemia	J:1780
	decreased body size	J:1780
	decreased hair follicle number	J:1780
	decreased leukocyte cell number	J:1780
	enlarged heart	J:1780
	fused podocyte foot processes	J:1780
	glomerulosclerosis	J:1780
	heart left ventricle hypertrophy	J:1780
	hypertension	J:1780
	kidney failure	J:1780
Tal1Hpt/Tal1Hpt (C57BL/6J x C3FeLe.B6-a/a)F1	abnormal coat appearance	J:13897
	abnormal hair follicle development	J:13897
	abnormal skin pigmentation	J:13897
	focal hair loss	J:13897
	sparse hair	J:13897
Tal1Hpt/Tal1Hpt HPT/Le	abnormal ectoderm development	J:1780
	embryonic lethality between implantation and somite formation, complete penetrance	J:1780
Tal1tm1(tTA)Bock/Tal1tm1(tTA)Bock involves: C57BL/6 * DBA/2	embryonic lethality	J:138070
Tal1tm1.1Bgo/Tal1tm1.1Bgo Not Specified	abnormal bone marrow cell morphology/development	J:203178
	normal hematopoietic system phenotype	J:203178
	increased hematopoietic stem cell number	J:203178
Tal1tm1Por/Tal1tm1Por involves: 129P2/OlaHsd	abnormal embryonic erythropoiesis	J:139179
	abnormal erythroid progenitor cell morphology	J:139179
	abnormal erythropoiesis	J:139179
	anisocytosis	J:139179
	decreased embryo size	J:139179
	decreased hematocrit	J:139179
	decreased hemoglobin content	J:139179
	decreased mean corpuscular hemoglobin concentration	J:139179
	decreased mean corpuscular volume	J:139179
	decreased survivor rate	J:139179
	extramedullary hematopoiesis	J:139179
	increased red blood cell distribution width	J:139179
	increased spleen weight	J:139179
	lethality throughout fetal growth and development, incomplete penetrance	J:139179
	microcytic anemia	J:139179
	pale yolk sac	J:139179
Tal1tm1Sho/Tal1tm1Sho involves: 129S4/SvJae	abnormal embryonic hematopoiesis	J:23061
	abnormal placental labyrinth vasculature morphology	J:23061
	absent common myeloid progenitor cells	J:23061
	absent visceral yolk sac blood islands	J:23061
	anemia	J:23061
	decreased embryo size	J:23061
	distended pericardium	J:23061
	embryo tissue necrosis	J:23061
	embryonic growth retardation	J:23061
	embryonic lethality during organogenesis, complete penetrance	J:23061
	incomplete somite formation	J:23061
	pallor	J:23061
Tal1tm1Wehi/Tal1tm1Wehi involves: 129S1/Sv * C57BL/6	abnormal embryonic hematopoiesis	J:27458
	absent visceral yolk sac blood islands	J:27458
	absent vitelline blood vessels	J:27458
	distended pericardium	J:27458
	embryonic growth arrest	J:27458
	embryonic growth retardation	J:27458
	embryonic lethality during organogenesis, complete penetrance	J:27458
	incomplete embryo turning	J:27458
	pale yolk sac	J:27458
	pallor	J:27458
	skin edema	J:27458
Tal1tm2Sho/Tal1tm2Sho Tg(Mx1-cre)1Cgn/0 involves: C57BL/6 * CBA	anemia	J:83215
	premature death	J:83215
	thrombocytopenia	J:83215
Tal1tm2Wehi/Tal1tm2Wehi involves: 129S1/Sv * C57BL/6	abnormal blood vessel morphology	J:58825
	abnormal embryonic hematopoiesis	J:58825
	abnormal heart development	J:58825
	abnormal vein morphology	J:58825
	absent visceral yolk sac blood islands	J:58825
	absent vitelline blood vessels	J:58825
	anemia	J:58825
	delayed heart looping	J:58825
	dilated dorsal aorta	J:58825
	disorganized yolk sac vascular plexus	J:58825
	distended pericardium	J:58825
	embryonic growth arrest	J:58825
	embryonic lethality during organogenesis, complete penetrance	J:58825
	hypoxia	J:58825
	increased neuron apoptosis	J:58825
	pericardial edema	J:58825
Tal1tm3Wehi/Tal1tm2Wehi Tg(Mx1-cre)1Cgn/0 involves: 129S1/Sv * C57BL/6 * CBA	abnormal bone marrow morphology	J:81826
	abnormal erythropoiesis	J:81826
	abnormal megakaryocyte morphology	J:81826
	abnormal megakaryocyte progenitor cell morphology	J:81826
	abnormal proerythroblast morphology	J:81826
	abnormal splenic cell ratio	J:81826
	anemia	J:81826
	decreased bone marrow cell number	J:81826
	impaired hematopoiesis	J:81826
	thrombocytopenia	J:81826
Tg(Lck-Tal1)4709Led/0 FVB/N-Tg(Lck-Tal1)4709Led	abnormal thymus morphology	J:36076
	enlarged liver	J:36076
	enlarged spleen	J:36076
	increased leukemia incidence	J:36076
	increased lymphoblastic lymphoma incidence	J:36076
	premature death	J:36076
	respiratory distress	J:36076
	ruffled hair	J:36076
	weight loss	J:36076